Ledger.Open graph →
SEC Form D · filed December 4, 2023

GelSana Therapeutics, Inc

Offering
$3.2M
Sold
$2.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
AURORA, CO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Mike Freeman · Aurora, CODirectorMelissa Krebs · Aurora, COExec · DirectorMike Freeman · Aurora, CODirectorMelissa Krebs · Aurora, COExec · DirectorJim Kasic · Denver, CODirectorDan Fipke · Houston, TXDirectorJake Bainbridge · Houston, TXExec · DirectorJim Kasic · Denver, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗